reported that after radiotherapy in patients with head and neck squamous cell carcinoma, the expression level of cyclin B1 is to be an important indicator of the risk of recurrence and metastasis (Hassan et al. 2002). Here, CCNB1 is linked to head and neck squamous cell carcinoma.